Search

Search Results
Results 161 - 170 of 176 for Acute myelogenous leukemia
  • Scientists sequence genome of a cancer patient
    News - 6 Nov 2008
    For the first time, scientists have decoded the complete DNA of a cancer patient and traced her disease - acute myelogenous leukemia - to its genetic roots.
  • Common garden plant may hold cure for leukemia
    News - 12 Dec 2005
    Scientists in the U.S. believe they have identified a new pathway in the progression of chronic myelogenous leukemia (CML).
  • Plant extract forskolin may lead to leukemia treatment
    News - 20 Nov 2005
    Scientists here have identified a new pathway in the progression of chronic myelogenous leukemia (CML). They also discovered that an extract from the root of a common ornamental plant can suppress the...
  • Developing smart drugs
    News - 30 Apr 2004
    Dana-Farber Cancer Institute Researchers, sensing an opening in the cancer battle, are mounting a quick thrust to flush out suspected molecular cancer triggers in tumor cells.
  • Zavedos
    Drug - 18 Jul 2025
    Consumer Medicine Information (CMI) about Zavedos intended for persons living in Australia.
  • Chemotherapy Principles
    Health - 22 Jun 2023
    The body is composed of many different types of cells that all grow, divide, and die in an orderly manner. This process is tightly regulated and controlled by the DNA machinery within cells.
  • What Causes Neutropenia?
    Health - 23 Feb 2023
    Neutropenia represents an abnormally low level of neutrophils in the blood.
  • Chronic Myelogenous Leukemia Risk Factors
    Health - 24 Jan 2023
    Chronic myeloid leukaemia or CML often begins when there is a change in the structure of DNA that affects the regulation of growth and maturity of the stem cells that produce white blood cells, red...
  • Chronic Myelogenous Leukemia Epidemiology
    Health - 24 Jan 2023
    Chronic myeloid leukemia or CML is one of the rare types of leukemia. It is rare worldwide.
  • Tyrosine Kinase Inhibitors for Targeted Cancer Therapy
    Life Sciences - 28 May 2021
    Tyrosine kinase inhibitors, which reduce or eliminate the intensity of aberrant signals, are under thorough investigation as anticancer agents.

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback